Cell biology of antigen processing in vitro and in vivo.

By E. Trombetta, I. Mellman. Annual Review of Immunology, 2005

1,215 citations recorded by the source corpus.

Subfields: Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/c816efa54b929065988ba5bf9db399f9ca95fb67

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. K. Palucka
2. Jacques Banchereau
3. R. Steinman
4. H. Hemmi
5. Ari Helenius
6. M. Hellmann
7. M. Swartz
8. G. Randolph

In Molecular Biology

1. V. Angeli
2. G. Randolph
3. Jacques Banchereau
4. Ari Helenius
5. Jatta Huotari
6. R. Steinman
7. M. Swartz
8. K. Palucka

Citations in the corpus

• Dendritic-cell-based therapeutic cancer vaccines. (2013, background): “, CCR7), which guide their migration (Trombetta and Mellman, 2005), and (4) the ability to secrete different cytokines (e.”
• Cancer immunotherapy via dendritic cells (2012, neutral): “In peripheral tissues, DCs capture antigens through several complementary mechanism”
• Endosome maturation (2011, background): “This phenomenon has been proposed for the recycling of MHC II in DCs, mannose-6phosphate receptors, and tetraspannin proteins, all of which are found to be enriched in ILVs (Kobayashi et al, 1998, 2002; Kleijmeer et al, 2001; Trombetta and Mellman, 2005).”
• Cancer immunotherapy comes of age (2011, neutral): “On antigen encounter, the dendritic cells would also have to receive a suitable activation (‘maturation’) signal, allowing them to differentiate extensively to promote immunity as opposed to tolerance including enhanced processing and presentation of tumour-antigen-derived peptide”
• Dendritic-cell trafficking to lymph nodes through lymphatic vessels (2005, background): “jpg" NDATA ITEM> ]> Dendritic cells (DCs) are widely accepted to be the most potent and versatile antigen-presenting cell in the immune system, owing to their superior capacity for acquiring and processing antigens for presentation to T cells and their potential to express high levels o”
• Dendritic cells: translating innate to adaptive immunity. (2006, background): “What is emerging from the ex vivo studies is a significant and perhaps unique regulation of the DC endocytic system at several levels (reviewed in [99]).”
• Acquired Resistance to Immune Checkpoint Inhibitors (2020, background): “The activation of T-cell mediated immunity is dependent upon the recognition of antigens on major histocompatibility complexes (MHCs) of antigen presenting cells (Blum et al., 2013; Trombetta and Mellman, 2005).”